Skip to main content

Articles

Page 1 of 77

  1. PANoptosis represents a novel type of programmed cell death (PCD) with distinctive features that incorporate elements of pyroptosis, apoptosis, and necroptosis. PANoptosis is governed by a newly discovered cyt...

    Authors: Lixia Gao, Chloe Shay and Yong Teng
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:168
  2. Authors: Nan Jing, Xinxing Du, Yu Liang, ZhenKeke Tao, Shijia Bao, Huixiang Xiao, Baijun Dong, Wei-Qiang Gao and Yu-Xiang Fang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:167

    The original article was published in Journal of Experimental & Clinical Cancer Research 2024 43:144

  3. Breast cancer (BC) is a complex disease, showing heterogeneity in the genetic background, molecular subtype, and treatment algorithm. Historically, treatment strategies have been directed towards cancer cells,...

    Authors: Vitale Del Vecchio, Ayesha Rehman, Sameer Kumar Panda, Martina Torsiello, Martina Marigliano, Maria Maddalena Nicoletti, Giuseppe Andrea Ferraro, Vincenzo De Falco, Rosamaria Lappano, Eva Lieto, Francesca Pagliuca, Carlo Caputo, Marcella La Noce, Gianpaolo Papaccio, Virginia Tirino, Nirmal Robinson…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:166
  4. Pancreatic ductal adenocarcinoma (PDAC) is the most lethal cancer with an aggressive metastatic phenotype and very poor clinical prognosis. Interestingly, a lower occurrence of PDAC has been described in indiv...

    Authors: Eduardo Ibello, Federica Saracino, Donatella Delle Cave, Silvia Buonaiuto, Filomena Amoroso, Gennaro Andolfi, Marco Corona, Ombretta Guardiola, Vincenza Colonna, Bruno Sainz Jr, Lucia Altucci, Dario De Cesare, Gilda Cobellis, Enza Lonardo, Eduardo Jorge Patriarca, Cristina D’Aniello…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:165
  5. Understanding the mechanisms that mediate the interaction between tumor and immune cells may provide therapeutic benefit to patients with cancer. The N6-methyladenosine (m6A) demethylase, ALKBH5 (alkB homolog ...

    Authors: Xin Hua, Qiuli Xu, Ranpu Wu, Wei Sun, Yanli Gu, Suhua Zhu, Xin Liu, Tangfeng Lv and Yong Song
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:164
  6. Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer subtype often treated with radiotherapy (RT). Due to its intrinsic heterogeneity and lack of effective targets, it is crucial t...

    Authors: Sushmitha Sriramulu, Shivani Thoidingjam, Wei-Min Chen, Oudai Hassan, Farzan Siddiqui, Stephen L. Brown, Benjamin Movsas, Michael D. Green, Anthony J. Davis, Corey Speers, Eleanor Walker and Shyam Nyati
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:163
  7. Authors: Luca Varinelli, Davide Battistessa, Marcello Guaglio, Susanna Zanutto, Oscar Illescas, Ewelina J. Lorenc, Federica Pisati, Shigeki Kusamura, Laura Cattaneo, Giovanna Sabella, Massimo Milione, Alessia Perbellini, Sara Noci, Cinzia Paolino, Elisabetta Kuhn, Margherita Galassi…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:162

    The original article was published in Journal of Experimental & Clinical Cancer Research 2024 43:132

  8. Cancer-associated fibroblasts (CAFs) play a significant role in fueling prostate cancer (PCa) progression by interacting with tumor cells. A previous gene expression analysis revealed that CAFs up-regulate gen...

    Authors: Valentina Doldi, Monica Tortoreto, Maurizio Colecchia, Massimo Maffezzini, Stefano Percio, Francesca Giammello, Federico Brandalise, Paolo Gandellini and Nadia Zaffaroni
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:161
  9. The tetraspanin family plays a pivotal role in the genesis of migrasomes, and Tetraspanin CD151 is also implicated in neovascularization within tumorous contexts. Nevertheless, research pertaining to the invol...

    Authors: Kangnan Zhang, Zhenhua Zhu, Rongrong Jia, NA Wang, Min Shi, Yugang Wang, Shihao Xiang, Qinghui Zhang and Ling Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:160
  10. Renal cell carcinoma (RCC) was historically considered to be less responsive to radiation therapy (RT) compared to other cancer indications. However, advancements in precision high-dose radiation delivery thro...

    Authors: Hari K. Rachamala, Vijay S. Madamsetty, Ramcharan S. Angom, Naga M. Nakka, Shamit Kumar Dutta, Enfeng Wang, Debabrata Mukhopadhyay and Krishnendu Pal
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:159
  11. Studies have shown that oxidative stress and its resistance plays important roles in the process of tumor metastasis, and mitochondrial dysfunction caused by mitochondrial DNA (mtDNA) damage is an important mo...

    Authors: Zhuan Zhou, Chunhui Qu, Peijun Zhou, Qin Zhou, Dan Li, Xia Wu and Lifang Yang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:158
  12. Phosphoinositide-3-kinase γ (PI3Kγ) plays a critical role in pancreatic ductal adenocarcinoma (PDA) by driving the recruitment of myeloid-derived suppressor cells (MDSC) into tumor tissues, leading to tumor gr...

    Authors: Claudia Curcio, Gianluca Mucciolo, Cecilia Roux, Silvia Brugiapaglia, Alessandro Scagliotti, Giorgia Guadagnin, Laura Conti, Dario Longo, Demis Grosso, Mauro Giulio Papotti, Emilio Hirsch, Paola Cappello, Judith A. Varner and Francesco Novelli
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:157
  13. Platinum-based chemotherapy regimens are a mainstay in the management of ovarian cancer (OC), but emergence of chemoresistance poses a significant clinical challenge. The persistence of ovarian cancer stem cel...

    Authors: Rula Atwani, Rohit Nagare, Amber Rogers, Mayuri Prasad, Virginie Lazar, George Sandusky, Yan Tong, Fabrizio Pin and Salvatore Condello
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:156
  14. Longitudinal sampling of tumor tissue from patients with solid cancers, aside from melanoma and a few other cases, is often unfeasible, and thus may not capture the plasticity of interactions between the tumor...

    Authors: Stephanie C. Pitts, Jeffrey Schlom and Renee N. Donahue
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:155
  15. RNA modifications of transfer RNAs (tRNAs) are critical for tRNA function. Growing evidence has revealed that tRNA modifications are related to various disease processes, including malignant tumors. However, t...

    Authors: Dan Du, Mingxia Zhou, Chenxi Ju, Jie Yin, Chang Wang, Xinyu Xu, Yunqing Yang, Yun Li, Le Cui, Zhengyang Wang, Yuqing Lei, Hongle Li, Fucheng He and Jing He
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:154
  16. Surgery represents the only curative treatment option for pancreatic ductal adenocarcinoma (PDAC), but recurrence in more than 85% of patients limits the success of curative-intent tumor resection. Neural inva...

    Authors: Andreas Göhrig, Georg Hilfenhaus, Friederike Rosseck, Martina Welzel, Benjamin Moser, Gianluca Barbone, Catarina Alisa Kunze, Johannes Rein, Gregor Wilken, Michael Böhmig, Thomas Malinka, Frank Tacke, Marcus Bahra, Katharina M. Detjen and Christian Fischer
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:153
  17. Intrahepatic cholangiocarcinoma (ICCA) is a heterogeneous group of malignant tumors characterized by high recurrence rate and poor prognosis. Heterochromatin Protein 1α (HP1α) is one of the most important nonh...

    Authors: Fei Xiong, Da Wang, Wei Xiong, Xin Wang, Wen-hua Huang, Guan-hua Wu, Wen-zheng Liu, Qi Wang, Jun-sheng Chen, Yi-yang Kuai, Bing Wang and Yong-jun Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:152
  18. SMYD3 has been found implicated in cancer progression. Its overexpression correlates with cancer growth and invasion, especially in gastrointestinal tumors. SMYD3 transactivates multiple oncogenic mechanisms, ...

    Authors: Paola Sanese, Katia De Marco, Martina Lepore Signorile, Francesca La Rocca, Giovanna Forte, Marialaura Latrofa, Candida Fasano, Vittoria Disciglio, Elisabetta Di Nicola, Antonino Pantaleo, Giusy Bianco, Vito Spilotro, Claudia Ferroni, Matilde Tubertini, Nicoletta Labarile, Lucia De Marinis…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:151
  19. Ovarian cancer has a high mortality rate mainly due to its resistance to currently used therapies. This resistance has been associated with the presence of cancer stem cells (CSCs), interactions with the micro...

    Authors: Elisa Suárez-Martínez, Sander R. Piersma, Thang V. Pham, Irene V. Bijnsdorp, Connie R. Jimenez and Amancio Carnero
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:150
  20. Prostate cancer (PCa) incidence and mortality rates are rising. Our previous research has shown that the combination of icariin (ICA) and curcumol (CUR) induced autophagy and ferroptosis in PCa cells, and alte...

    Authors: Wenjing Xu, Yingqiu Li, Lumei Liu, Jing Xie, Zongren Hu, Shida Kuang, Xinying Fu, Bonan Li, Tiansong Sun, Congxu Zhu, Qinghu He and Wen Sheng
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:149
  21. Primary mediastinal B-cell lymphoma (PMBL) and classical Hodgkin lymphoma (cHL) are distinct hematological malignancies of B-cell origin that share many biological, molecular, and clinical characteristics. In ...

    Authors: Manon Durand, Vincent Cabaud Gibouin, Laurence Duplomb, Leila Salmi, Mélody Caillot, Brigitte Sola, Vincent Camus, Fabrice Jardin, Carmen Garrido and Gaëtan Jego
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:148
  22. A century ago, the Warburg effect was first proposed, revealing that cancer cells predominantly rely on glycolysis during the process of tumorigenesis, even in the presence of abundant oxygen, shifting the mai...

    Authors: Fan Guan, Xiaomin Wu, Jiatong Zhou, Yuzhe Lin, Yuqing He, Chunmei Fan, Zhaoyang Zeng and Wei Xiong
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:147
  23. Over the last few decades, the incidence of urogenital cancers has exhibited diverse trends influenced by screening programs and geographical variations. Among women, there has been a consistent or even increa...

    Authors: Giada De Lazzari, Alena Opattova and Sabrina Arena
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:146
  24. Plasma cell-free DNA (cfDNA) fragmentomics has demonstrated significant differentiation power between cancer patients and healthy individuals, but little is known in pancreatic and biliary tract cancers. The a...

    Authors: Xiaohan Shi, Shiwei Guo, Qiaonan Duan, Wei Zhang, Suizhi Gao, Wei Jing, Guojuan Jiang, Xiangyu Kong, Penghao Li, Yikai Li, Chuanqi Teng, Xiaoya Xu, Sheng Chen, Baoning Nian, Zhikuan Li, Chaoliang Zhong…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:145
  25. Neuroendocrine prostate cancer (NEPC) is a lethal subset of prostate cancer which is characterized by neuroendocrine differentiation and loss of androgen receptor (AR) signaling. Growing evidence reveals that ...

    Authors: Nan Jing, Xinxing Du, Yu Liang, ZhenKeke Tao, Shijia Bao, Huixiang Xiao, Baijun Dong, Wei-Qiang Gao and Yu-Xiang Fang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:144

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2024 43:167

  26. Sorafenib is a standard first-line treatment for advanced hepatocellular carcinoma (HCC), yet its effectiveness is often constrained. Emerging studies reveal that sorafenib triggers ferroptosis, an iron-depend...

    Authors: Jiarui Li, Yilan Li, Denghui Wang, Rui Liao and Zhongjun Wu
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:143
  27. Mounting evidences shows that the ubiquitin‒proteasome pathway plays a pivotal role in tumor progression. The expression of 26S proteasome non-ATPase regulatory subunit 9 (PSMD9) is correlated with recurrence ...

    Authors: Yuting Su, Lili Meng, Chao Ge, Yuqi Liu, Chi Zhang, Yue Yang, Wei Tian and Hua Tian
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:142
  28. Neuroblastoma (NB) patients with amplified MYCN often face a grim prognosis and are resistant to existing therapies, yet MYCN protein is considered undruggable. KAP1 (also named TRIM28) plays a crucial role in...

    Authors: Yi Yang, Yingwen Zhang, Guoyu Chen, Bowen Sun, Fei Luo, Yijin Gao, Haizhong Feng and Yanxin Li
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:141
  29. PTEN loss has been identified in various tumor types and is linked to unfavorable clinical outcomes. In addition to PTEN mutation, multiple mechanisms contribute to PTEN loss during tumor development. However,...

    Authors: Ming Wang, Zhenzhen Pan, Xu Chu, Xiaohan Yao, Xixi Duan, Jiajia Wan, Xiaohan Lou, Wenqing Li, Yan Yan, Lin Chen, Junfeng An and Zhihai Qin
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:140
  30. LncRNAs regulate tumorigenesis and development in a variety of cancers. We substantiate for the first time that LINC00606 is considerably expressed in glioblastoma (GBM) patient specimens and is linked with ad...

    Authors: Naijun Dong, Wenxin Qi, Lingling Wu, Jie Li, Xueqi Zhang, Hao Wu, Wen Zhang, Jiawen Jiang, Shibo Zhang, Wenjun Fu, Qian Liu, Guandong Qi, Lukai Wang, Yanyuan Lu, Jingyi Luo, Yanyan Kong…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:139
  31. Although immune checkpoint blockade (ICB) therapy has proven to be extremely effective at managing certain cancers, its efficacy in treating pancreatic ductal adenocarcinoma (PDAC) has been limited. Therefore,...

    Authors: PingShan Zhong, Kohei Nakata, Koki Oyama, Nobuhiro Higashijima, Akiko Sagara, Satomi Date, HaiZhen Luo, Masataka Hayashi, Akihiro Kubo, ChenYi Wu, Shan He, Takeo Yamamoto, Kazuhiro Koikawa, Chika Iwamoto, Toshiya Abe, Naoki Ikenaga…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:138
  32. The C-terminal-binding protein 1/brefeldin A ADP-ribosylation substrate (CtBP1/BARS) acts both as an oncogenic transcriptional co-repressor and as a fission inducing protein required for membrane trafficking a...

    Authors: Angela Filograna, Stefano De Tito, Matteo Lo Monte, Rosario Oliva, Francesca Bruzzese, Maria Serena Roca, Antonella Zannetti, Adelaide Greco, Daniela Spano, Inmaculada Ayala, Assunta Liberti, Luigi Petraccone, Nina Dathan, Giuliana Catara, Laura Schembri, Antonino Colanzi…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:137
  33. Hepatocellular carcinoma (HCC) is a fatal malignancy with poor prognosis due to lack of effective clinical interference. DCAF1 plays a vital role in regulating cell growth and proliferation, and is involved in...

    Authors: Jinyao Zhang, Yuze Shi, Ke Ding, Weiwei Yu, Jianbo He and Beicheng Sun
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:136
  34. Rhabdomyosarcoma (RMS) is a rare malignancy and the most common soft tissue sarcoma in children. Vasculogenic mimicry (VM) is a novel tumor microcirculation model different from traditional tumor angiogenesis,...

    Authors: Ruyue Zhang, Daidi Zhang, Fugen Han, Xiaorui Song, Yaodong Zhang, Jie Zhang, Qingwen Zhu and Yanru Qin
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:135
  35. Mucosal-associated invariant T (MAIT) cells have been reported to regulate tumor immunity. However, the immune characteristics of MAIT cells in non-small cell lung cancer (NSCLC) and their correlation with the...

    Authors: Jingjing Qu, Binggen Wu, Lijun Chen, Zuoshi Wen, Liangjie Fang, Jing Zheng, Qian Shen, Jianfu Heng, Jianya Zhou and Jianying Zhou
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:134
  36. Targeting ferroptosis has been identified as a promising approach for the development of cancer therapies. Monounsaturated fatty acid (MUFA) is a type of lipid that plays a crucial role in inhibiting ferropto...

    Authors: Yanmei Yuan, Junting Xu, Quanxin Jiang, Chuanxin Yang, Ning Wang, Xiaolong Liu, Hai-long Piao, Sijia Lu, Xianjing Zhang, Liu Han, Zhiyan Liu, Jiabin Cai, Fang Liu, Suzhen Chen and Junli Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:133
  37. Peritoneal metastases from colorectal cancer (CRCPM) are related to poor prognosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been reported to improve survival, but...

    Authors: Luca Varinelli, Davide Battistessa, Marcello Guaglio, Susanna Zanutto, Oscar Illescas, Ewelina J. Lorenc, Federica Pisati, Shigeki Kusamura, Laura Cattaneo, Giovanna Sabella, Massimo Milione, Alessia Perbellini, Sara Noci, Cinzia Paolino, Elisabetta Kuhn, Margherita Galassi…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:132

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2024 43:162

  38. Authors: Yaya Qiao, Meng Su, Huifang Zhao, Huanle Liu, Chenxi Wang, Xintong Dai, Lingling Liu, Guangju Liu, Huanran Sun, Mingming Sun, Jiyan Wang, Zhen Li, Jun Fan, Quan Zhang, Chunshen Li, Fangmin Situ…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:131

    The original article was published in Journal of Experimental & Clinical Cancer Research 2024 43:108

  39. Medulloblastomas (MBs) are one of the most common malignant brain tumor types in children. MB prognosis, despite improvement in recent years, still depends on clinical and biological risk factors. Metastasis i...

    Authors: Anh Duy Do, Kuo-Sheng Wu, Shing-Shung Chu, Le Hien Giang, Yu-Ling Lin, Che-Chang Chang, Tai-Tong Wong, Chia-Ling Hsieh and Shian-Ying Sung
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:130
  40. Circulating tumor cells (CTCs) hold immense promise in guiding treatment strategies for advanced gastric cancer (GC). However, their clinical impact has been limited due to challenges in identifying epithelial...

    Authors: Heming Li, Yang-Zhuangzhuang Zhu, Lu Xu, Tao Han, Jiasi Luan, Xin Li, Yuting Liu, Zhi Wang, Qiuge Liu, Xiangyu Kong, Chunpu Zou, Lin Su, Yifei Hou, Xiao Chen, Lujun Chen, Ruoyu Wang…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:129
  41. Brain metastasis is one of the main causes of recurrence and death in non-small cell lung cancer (NSCLC). Although radiotherapy is the main local therapy for brain metastasis, it is inevitable that some cancer...

    Authors: Lichao Liu, Jian Wang, Ying Wang, Lingjuan Chen, Ling Peng, Yawen Bin, Peng Ding, Ruiguang Zhang, Fan Tong and Xiaorong Dong
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:128
  42. TP53, the most frequently mutated gene in human cancers, orchestrates a complex transcriptional program crucial for cancer prevention. While certain TP53-dependent genes have been extensively studied, others, ...

    Authors: Etna Abad, Jérémy Sandoz, Gerard Romero, Ivan Zadra, Julia Urgel-Solas, Pablo Borredat, Savvas Kourtis, Laura Ortet, Carlos M. Martínez, Donate Weghorn, Sara Sdelci and Ana Janic
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:127
  43. Aberrant alternative splicing (AS) is a pervasive event during colorectal cancer (CRC) development. SF3B3 is a splicing factor component of U2 small nuclear ribonucleoproteins which are crucial for early stage...

    Authors: Tong Xu, Xichuan Li, Wennan Zhao, Xue Wang, Leixin Jin, Zhiqiang Feng, Huixiang Li, Mingzhe Zhang, Yiqing Tian, Ge Hu, Yuan Yue, Xintong Dai, Changliang Shan, Weihua Zhang, Chunze Zhang and Youcai Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:126
  44. Immunotherapy has emerged as a potent clinical approach for cancer treatment, but only subsets of cancer patients can benefit from it. Targeting lactate metabolism (LM) in tumor cells as a method to potentiate...

    Authors: Dongjie Chen, Pengyi Liu, Xiongxiong Lu, Jingfeng Li, Debin Qi, Longjun Zang, Jiayu Lin, Yihao Liu, Shuyu Zhai, Da Fu, Yuanchi Weng, Hongzhe Li and Baiyong Shen
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:125
  45. Esophageal squamous cell carcinoma (ESCC) is a common gastrointestinal tumor and has become an important global health problem. The PI3K/AKT signaling pathway plays a key role in the development of ESCC. CircR...

    Authors: Kai Lei, Ruihao Liang, Jialu Liang, Nan Lu, Jing Huang, Ke Xu, Binghua Tan, Kexi Wang, Yicheng Liang, Wenjian Wang, Huayue Lin and Minghui Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:124
  46. Aberrant fucosylation observed in cancer cells contributes to an augmented release of fucosylated exosomes into the bloodstream, where miRNAs including miR-4732-3p hold promise as potential tumor biomarkers in...

    Authors: Wanzhen Zhuang, Chengxiu Liu, Yilin Hong, Yue Zheng, Minjian Huang, Haijun Tang, Lilan Zhao, Zhixin Huang, Mingshu Tu, Lili Yu, Jianlin Chen, Yi Zhang, Xiongfeng Chen, Fan Lin, Qi Gao, Chundong Yu…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:123
  47. Radiation therapy stands to be one of the primary approaches in the clinical treatment of malignant tumors. Nasopharyngeal Carcinoma, a malignancy predominantly treated with radiation therapy, provides an inva...

    Authors: Hongke Qu, Yumin Wang, Qijia Yan, Chunmei Fan, Xiangyan Zhang, Dan Wang, Can Guo, Pan Chen, Lei Shi, Qianjin Liao, Ming Zhou, Fuyan Wang, Zhaoyang Zeng, Bo Xiang and Wei Xiong
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:122
  48. Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and chemotherapy still serves as the cornerstone treatment functioning by inducing cytotoxic cell death. Notably, emerging ...

    Authors: Shengqi Wang, Jing Li, Shicui Hong, Neng Wang, Shang Xu, Bowen Yang, Yifeng Zheng, Juping Zhang, Bo Pan, Yudie Hu and Zhiyu Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:121
  49. Authors: Laura Micheli, Carmen Parisio, Elena Lucarini, Alessia Vona, Alessandra Toti, Alessandra Pacini, Tommaso Mello, Serena Boccella, Flavia Ricciardi, Sabatino Maione, Grazia Graziani, Pedro Miguel Lacal, Paola Failli, Carla Ghelardini and Lorenzo Di Cesare Mannelli
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:120

    The original article was published in Journal of Experimental & Clinical Cancer Research 2021 40:320

  50. Refractoriness to surgical resection and chemotherapy makes intrahepatic cholangiocarcinoma (ICC) a fatal cancer of the digestive system with high mortality and poor prognosis. Important function invests circR...

    Authors: Jing Li, Xiaohong Xu, Kaihao Xu, Xueliang Zhou, Kunpeng Wu, Yuan Yao, Zaoqu Liu, Chen Chen, Ling Wang, Zhenqiang Sun, Dechao Jiao and Xinwei Han
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:119

Annual Journal Metrics

  • 2022 Citation Impact
    11.3 - 2-year Impact Factor
    11.5 - 5-year Impact Factor
    1.870 - SNIP (Source Normalized Impact per Paper)
    2.413 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    100 days submission to accept (Median)

    2023 Usage 
    3,003,080 downloads
    3,022 Altmetric mentions